"randomised, multicentre, double-blind, placebo-controlled study of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)"
عنوان الدراسة
"randomised, multicentre, double-blind, placebo-controlled study of ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension (CTEPH)"
داعم الدراسة
GSK
دواء الدراسة
Ambrisentan 5 mg
رقم بروتوكول الدراسة
AMB115811
حالة الدراسة
Completed
موقع الدراسة
KFMC
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.